Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Fudan University
Astellas Pharma Inc
Coherus Oncology, Inc.
I-Mab Biopharma US Limited
University Hospital, Akershus
AstraZeneca
UNICANCER
NuCana plc
Memorial Sloan Kettering Cancer Center
Imugene Limited
IGM Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Tyme, Inc
Taiho Pharmaceutical Co., Ltd.
Ruijin Hospital
OHSU Knight Cancer Institute
Asan Medical Center
Hoosier Cancer Research Network
National Cancer Institute, Naples
H. Lee Moffitt Cancer Center and Research Institute
Ludwig-Maximilians - University of Munich
Federation Francophone de Cancerologie Digestive
Groupe Oncologie Radiotherapie Tete et Cou
EMD Serono
GSO Global Clinical Research BV
Translational Oncology Research International
Grupo Espanol Multidisciplinario del Cancer Digestivo
Sun Yat-sen University
AIO-Studien-gGmbH
UNICANCER
UNICANCER
University of Florida
American College of Radiology Imaging Network
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Daiichi Sankyo
Eli Lilly and Company
mAbxience Research S.L.
Sixth Affiliated Hospital, Sun Yat-sen University
Abramson Cancer Center at Penn Medicine
Epidemiological and Clinical Research Information Network
M.D. Anderson Cancer Center
Amgen
Sun Yat-sen University
Galectin Therapeutics Inc.
European Organisation for Research and Treatment of Cancer - EORTC
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute